Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
about
A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic diseaseDendritic cells and immunotherapy for malignant disease.How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.Dendritic cell-based immunotherapy in multiple myeloma.DNA fusion gene vaccines against cancer: from the laboratory to the clinic.EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in functionEnhancement of clonogenicity of human multiple myeloma by dendritic cellsMolecular profiling of tumor-specific TH1 cells activated in vivo.In Vivo Cellular Imaging for Translational Medical Research.ANCA patients have T cells responsive to complementary PR-3 antigenDominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Immunotherapy for multiple myeloma.Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing.Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications.Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells.Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display.Dendritic cell cancer vaccines: from the bench to the bedside.Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.Liver metastasis of cancer facilitated by chemokine receptor CCR6.
P2860
Q27329429-E453A8D9-7781-4192-A5D6-CCB7DF8B7A38Q34216506-348402B7-FDD6-4033-A0C1-2C941F95A195Q34418112-B0448AE6-BDDB-4927-9FF1-FDC748CCDE8DQ34557219-D7520F73-3A8F-44AA-B858-71412AA9A911Q35665926-BD24FC14-F5C1-4898-A49E-BC0EFFA70A07Q35826392-1389A1D1-1BEA-4116-B0FF-AA23BDF1B464Q36001430-B4DF0CBC-55B5-426F-8091-8301F31E29EDQ36082990-737CD1B5-E98E-4345-A7BA-EA584F119810Q36887852-ABD73799-BAC2-4FE0-81CB-E02F96F8D94BQ37352907-C3F8BD54-BB30-469E-8BA6-BB8C17D7D58CQ37369259-697404EE-4FD2-4904-A643-34DEEC2F871DQ37396070-FC858A58-425A-4EEE-8D73-E7F0B6FDFE25Q37851180-1967C778-8617-4B18-AD30-0F99E8079D77Q38014834-FEB96AD9-C60B-4A4C-BE74-5E06DADA0D2FQ38177879-103B381D-EFEA-459A-93DB-51698F8A4066Q39589735-B84C07BD-8207-4A37-AD9E-454569804F1AQ40183444-56EAF2BE-6284-4A29-A8F2-C95C13DD7C4EQ41648531-B99F0985-9EB9-499C-AC49-5A7ED45C98FEQ41910513-14946335-0544-4B5F-B9B9-1A3CB466ABFDQ42979673-4212836F-973D-4764-97A4-55F1B81478DCQ47239271-8BE2DC20-644E-41DF-8634-0062C6B078F0Q50764677-62822AB3-9947-42AE-B3F4-05EB96AEAB7D
P2860
Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@ast
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@en
type
label
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@ast
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@en
prefLabel
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@ast
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@en
P2093
P2860
P356
P1476
Dendritic cells purified from ...... pe) and activate CD4+ T cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.050579897
P407
P577
2000-03-01T00:00:00Z